THE USE OF SENOLYTIC AGENT TO IMPROVE THE BENEFIT OF PLATELET-RICH PLASMA AND LOSARTAN FOR TREATMENT OF FEMOROACETABULAR IMPINGEMENT AND LABRAL TEAR: A PILOT STUDY
$2,000,000FY2021Department of the NavyDOD
Steadman Philippon Research Institute, Vail CO